FI933291A - Foerfarande foer paovisning av anti-rna-antikroppar - Google Patents

Foerfarande foer paovisning av anti-rna-antikroppar Download PDF

Info

Publication number
FI933291A
FI933291A FI933291A FI933291A FI933291A FI 933291 A FI933291 A FI 933291A FI 933291 A FI933291 A FI 933291A FI 933291 A FI933291 A FI 933291A FI 933291 A FI933291 A FI 933291A
Authority
FI
Finland
Prior art keywords
pct
rna
paovisning
antikroppar
foerfarande foer
Prior art date
Application number
FI933291A
Other languages
English (en)
Other versions
FI933291A0 (fi
FI107359B (fi
Inventor
Venrooij Walther Jacobus Van
Rene Antonius Hoet
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of FI933291A0 publication Critical patent/FI933291A0/fi
Publication of FI933291A publication Critical patent/FI933291A/fi
Application granted granted Critical
Publication of FI107359B publication Critical patent/FI107359B/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/564—Immunoassay; Biospecific binding assay; Materials therefor for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Hematology (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Rehabilitation Therapy (AREA)
  • Rheumatology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FI933291A 1991-01-22 1993-07-21 Menetelmä anti-RNA-vasta-aineiden toteamiseksi FI107359B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP91200121 1991-01-22
EP91200121 1991-01-22
PCT/EP1992/000106 WO1992013276A1 (en) 1991-01-22 1992-01-16 Method for detection of anti-rna-antibodies
EP9200106 1992-01-16

Publications (3)

Publication Number Publication Date
FI933291A0 FI933291A0 (fi) 1993-07-21
FI933291A true FI933291A (fi) 1993-08-18
FI107359B FI107359B (fi) 2001-07-13

Family

ID=8207502

Family Applications (1)

Application Number Title Priority Date Filing Date
FI933291A FI107359B (fi) 1991-01-22 1993-07-21 Menetelmä anti-RNA-vasta-aineiden toteamiseksi

Country Status (15)

Country Link
US (1) US5385824A (fi)
EP (1) EP0568554B1 (fi)
JP (1) JP3288041B2 (fi)
KR (1) KR100244799B1 (fi)
AT (1) ATE126599T1 (fi)
AU (1) AU658860B2 (fi)
CA (1) CA2101166C (fi)
DE (1) DE69204157T2 (fi)
DK (1) DK0568554T3 (fi)
ES (1) ES2078733T3 (fi)
FI (1) FI107359B (fi)
GR (1) GR3017975T3 (fi)
IE (1) IE66750B1 (fi)
WO (1) WO1992013276A1 (fi)
ZA (1) ZA92389B (fi)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5576186A (en) * 1994-09-01 1996-11-19 The University Of Kansas Diagnosis and monitoring of rheumatological diseases by detection of anti-EF1-α antibodies
US20070037144A1 (en) * 2000-10-20 2007-02-15 Jay Wohlgemuth Leukocyte expression profiling
US7026121B1 (en) 2001-06-08 2006-04-11 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US6905827B2 (en) * 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) * 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7892745B2 (en) * 2003-04-24 2011-02-22 Xdx, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US7645575B2 (en) * 2004-09-08 2010-01-12 Xdx, Inc. Genes useful for diagnosing and monitoring inflammation related disorders
EP1885889A4 (en) * 2005-05-11 2010-01-20 Expression Diagnostics Inc METHOD FOR MONITORING THE OPERATING STATUS OF TRANSPLANTS OVER GENLISTS
CA2648580A1 (en) * 2006-04-07 2008-05-02 Xdx, Inc. Steroid responsive nucleic acid expression and prediction of disease activity
WO2008021431A2 (en) * 2006-08-14 2008-02-21 Xdx, Inc. Methods and compositions for diagnosing and monitoring the status of transplant rejection and immune disorders
EP2102367A2 (en) * 2006-11-09 2009-09-23 XDX, Inc. Methods for diagnosing and monitoring the status of systemic lupus erythematosus
WO2012068107A2 (en) * 2010-11-17 2012-05-24 University Of Florida Research Foundation, Inc. Autoantibody to rna-protein complex detected by quantitative pcr
US20170044591A1 (en) * 2014-04-24 2017-02-16 Alnylam Pharmaceuticals, Inc. Methods and compositions for detecting anti-drug antibodies

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4784942A (en) * 1984-11-05 1988-11-15 The Board Of Regents For The University Of Oklahoma Monoclonal antibodies against autoimmune RNA proteins
CA2050340A1 (en) * 1989-02-27 1990-08-28 Corgenix, Inc. Method and diagnostic test kit for detection of autoimmune antibody

Also Published As

Publication number Publication date
JP3288041B2 (ja) 2002-06-04
IE66750B1 (en) 1996-02-07
JPH06504620A (ja) 1994-05-26
US5385824A (en) 1995-01-31
AU1161592A (en) 1992-08-27
DE69204157T2 (de) 1996-03-21
AU658860B2 (en) 1995-05-04
FI933291A0 (fi) 1993-07-21
EP0568554B1 (en) 1995-08-16
GR3017975T3 (en) 1996-02-29
EP0568554A1 (en) 1993-11-10
ES2078733T3 (es) 1995-12-16
DE69204157D1 (de) 1995-09-21
DK0568554T3 (da) 1995-12-04
WO1992013276A1 (en) 1992-08-06
FI107359B (fi) 2001-07-13
KR100244799B1 (ko) 2000-03-02
CA2101166A1 (en) 1992-07-23
IE920132A1 (en) 1992-07-29
CA2101166C (en) 2003-05-20
ATE126599T1 (de) 1995-09-15
KR930703612A (ko) 1993-11-30
ZA92389B (en) 1992-09-30

Similar Documents

Publication Publication Date Title
SE9103332D0 (sv) Method for the diagnosis of blood coagulation desorders
FI933291A0 (fi) Foerfarande foer paovisning av anti-rna-antikroppar
EP1099102A4 (en) TRACE DETECTION OF ANALYTES BY ARTIFICIAL OLFAKTOMETRY
DE3751318D1 (de) Arthroskopische chirurgische Vorrichtung.
ES2138729T3 (es) Metodos de diagnostico de la preeclampsia.
DE69228824D1 (de) NACHWEISMETHODEN FÜR C-Raf-1-GENES.5
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
ES2093277T3 (es) Metodo para la deteccion de daño epitelial gastrico.
MX9206339A (es) Nueva proteina inhibidora de trombina a partir de chinches de monte
AU5336796A (en) Method for detecting allergy
NO883288L (no) Anordning for bestemmelse av blod.
ATE237139T1 (de) Verfahren zur identifizierung personen empfindlich für betahemolytischer streptococci- vermittelter neuropsychiatrischer krankheiten
RU94014977A (ru) Способ оценки уровня серонина в цельной крови
IT8820881A0 (it) Dispositivo per il trattamento di sangue.
AU578661B2 (en) Method for diagnosis of A.I.D.S.
Pearlman Late luteal phase dysphoric disorder and DSM-III-R
NO853413L (no) Fremgangsmaate for bestemmelse av blod i avfoering.
UA34212A (uk) Спосіб оцінки результатів лікування хворих на ранні форми сифілісу
UA6640A (uk) Спосіб прогнозування загострення супутнього захворювання при активізації основної патології
IT8720999A0 (it) Poli (2,6-dimetil-p-ossifenilene)modificato, procedimento per la sua preparazione e sua utilizzazione.
UA9626A (uk) Спосіб діагностики вперше виявленого туберкульозу легень
DE69319140D1 (de) 4-guanidinobutyramid zur verbesserung des blutkreislaufs
ES2127133B1 (es) Utilizacion de derivados 2,5-dihidroxibencenosulfonicos para la fabricacion de medicamentos destinados al tratamiento y a la prevencion de la enfermedad de alzheimer.
IT8221232V0 (it) Dispositivo di lettura, particolarmente utile per persone anziane, musicisti, ammalati, handicappati e simili.

Legal Events

Date Code Title Description
MM Patent lapsed